Clal Insurance Enterprises Holdings LTD Sol Gel Technologies Ltd. Transaction History

Clal Insurance Enterprises Holdings LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$7.7 - $10.48 $484,699 - $659,695	-62,948 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.78 - $9.49 $20,075 - $28,099	2,961 Added 4.94%	62,948 $573,000
Q1 2019 May 14, 2019	BUY	$5.71 - $7.19 $342,525 - $431,306	59,987 New	59,987 $406,000

5.38M

20.1K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $176M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.